Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rapid evaluation after high-risk TIA is associated with lower stroke risk.
Wu CM, Manns BJ, Hill MD, Ghali WA, Donaldson C, Buchan AM. Wu CM, et al. Among authors: manns bj. Can J Neurol Sci. 2009 Jul;36(4):450-5. doi: 10.1017/s0317167100007770. Can J Neurol Sci. 2009. PMID: 19650355
Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia.
Manns B, Hyndman E, Burgess E, Parsons H, Schaefer J, Snyder F, Scott-Douglas N. Manns B, et al. Kidney Int. 2001 Mar;59(3):1103-9. doi: 10.1046/j.1523-1755.2001.0590031103.x. Kidney Int. 2001. PMID: 11231366 Clinical Trial.
An economic evaluation of early versus late referral of patients with progressive renal insufficiency.
McLaughlin K, Manns B, Culleton B, Donaldson C, Taub K. McLaughlin K, et al. Among authors: manns b. Am J Kidney Dis. 2001 Nov;38(5):1122-8. doi: 10.1053/ajkd.2001.28619. Am J Kidney Dis. 2001. PMID: 11684571
To reuse or not to reuse? An economic evaluation of hemodialyzer reuse versus conventional single-use hemodialysis for chronic hemodialysis patients.
Manns BJ, Taub K, Richardson RM, Donaldson C. Manns BJ, et al. Int J Technol Assess Health Care. 2002 Winter;18(1):81-93. Int J Technol Assess Health Care. 2002. PMID: 11987444
Costing health care procedures: art or science?
Currie GR, Manns B. Currie GR, et al. Among authors: manns b. Can J Gastroenterol. 2002 Jul;16(7):467-9. doi: 10.1155/2002/364180. Can J Gastroenterol. 2002. PMID: 12177725 No abstract available.
Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.
Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson C. Lee H, et al. Among authors: manns b. Am J Kidney Dis. 2002 Sep;40(3):611-22. doi: 10.1053/ajkd.2002.34924. Am J Kidney Dis. 2002. PMID: 12200814
An economic evaluation of activated protein C treatment for severe sepsis.
Manns BJ, Lee H, Doig CJ, Johnson D, Donaldson C. Manns BJ, et al. N Engl J Med. 2002 Sep 26;347(13):993-1000. doi: 10.1056/NEJMsa020969. N Engl J Med. 2002. PMID: 12324556
Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery.
Manns B, Doig CJ, Lee H, Dean S, Tonelli M, Johnson D, Donaldson C. Manns B, et al. Crit Care Med. 2003 Feb;31(2):449-55. doi: 10.1097/01.CCM.0000045182.90302.B3. Crit Care Med. 2003. PMID: 12576950
The epidemiology of severe sepsis syndrome and its treatment with recombinant human activated protein C.
Doig CJ, Laupland KB, Zygun DA, Manns BJ. Doig CJ, et al. Among authors: manns bj. Expert Opin Pharmacother. 2003 Oct;4(10):1789-99. doi: 10.1517/14656566.4.10.1789. Expert Opin Pharmacother. 2003. PMID: 14521488 Review.
Detailed cost analysis of care for survivors of severe sepsis.
Lee H, Doig CJ, Ghali WA, Donaldson C, Johnson D, Manns B. Lee H, et al. Among authors: manns b. Crit Care Med. 2004 Apr;32(4):981-5. doi: 10.1097/01.ccm.0000120053.98734.2c. Crit Care Med. 2004. PMID: 15071389